AMRX SG&A Expense Growth
Amneal Pharmaceuticals Inc Class A · SG&A Expense Growth
AMRX SG&A Expense Growth
Latest reported10.58%period ending
AMRX FY SG&A Growth (YoY) (0.00% → 10.58%)
Latest values, visible window
High-resolution chart · PNG
AMRX sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 10.5767% | |
| 10.8829% | |
| 7.4994% | |
| 9.3558% | |
| 11.8683% | |
| 12.8209% | |
| 25.6745% | |
| 111.3191% | |
| -8.1772% | |
| 8.2769% | |
| 29.6212% | |
| 0% |